Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only

Home/WV/Huntington

Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Huntington, WV

Studies commonly pay $75 to $4,500 per completed study

55 clinical trials are currently recruiting participants within 30 miles of Huntington. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

55studies recruiting

4+research centers nearby

6condition categories

Live from the NIH registry

Studies recruiting near Huntington right now

Top 25 of 55 recruiting studies, sorted by proximity — each links to its official registry page

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

Opioid Use Disorder, Opioid Use Disorder, Moderate Phase 2 Interventional 310 participants sought

Marshall Health — Huntington, West Virginia (0.8 mi) · Sponsor: T. John Winhusen, PhD

See eligibility & contact on ClinicalTrials.gov (NCT06651177)

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Phase 2 Interventional 474 participants sought

Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT06632977)

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Breast Cancer Phase 3 Interventional 3,960 participants sought

King's Daughter's Medical Center — Ashland, Kentucky (12.0 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05879926)

Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.

Opioid Use Disorder Phase 4 Interventional 600 participants sought

Marshall University Division of Addiction Sciences P.R.O.A.C.T — Huntington, West Virginia (0.8 mi) · Sponsor: Yale University

See eligibility & contact on ClinicalTrials.gov (NCT06323824)

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor Phase 2 Interventional 256 participants sought

Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: Children's Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT04322318)

A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine

Migraine Phase 3 Interventional 600 participants sought

Marshall University Medical Center — Huntington, West Virginia (0.8 mi) · Sponsor: H. Lundbeck A/S

See eligibility & contact on ClinicalTrials.gov (NCT05164172)

Project: Every Child for Younger Patients With Cancer

Adrenal Gland Pheochromocytoma, Carcinoma In Situ N/A Observational 75,000 participants sought

Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: Children's Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT02402244)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma Phase 3 Interventional 1,210 participants sought

Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT04267848)

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8 Phase 3 Interventional 304 participants sought

Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06096844)

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 626 participants sought

Local Institution - Unk064 — Huntington, West Virginia (0.8 mi) · Sponsor: Mirati Therapeutics Inc.

See eligibility & contact on ClinicalTrials.gov (NCT04613596)

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Pulmonary Hypertension Due to Lung Diseases and Hypoxia, Pulmonary Hypertension N/A Observational 900 participants sought

Marshall Health — Huntington, West Virginia (0.8 mi) · Sponsor: United Therapeutics

See eligibility & contact on ClinicalTrials.gov (NCT06388421)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8 Phase 2 Interventional 2,900 participants sought

Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05564377)

Responding With Evidence and Access for Childhood Headaches

Headache, Headache Disorders N/A Interventional 400 participants sought

Marshall Health — Huntington, West Virginia (0.8 mi) · Sponsor: Children's Hospital Medical Center, Cincinnati

See eligibility & contact on ClinicalTrials.gov (NCT05889624)

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Lung Non-Small Cell Carcinoma Phase 2 Interventional 88 participants sought

Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: SWOG Cancer Research Network

See eligibility & contact on ClinicalTrials.gov (NCT06116682)

IBS Skin Patch Test Food Allergy Study

Irritable Bowel Syndrome N/A Interventional 250 participants sought

Shepherd Allergy — Barboursville, West Virginia (7.6 mi) · Sponsor: IBS-80, LLC

See eligibility & contact on ClinicalTrials.gov (NCT06288672)

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 Phase 3 Interventional 1,875 participants sought

Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05675410)

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

Lumbar Spinal Stenosis N/A Observational 8,000 participants sought

Cabell Huntington Hospital — Huntington, West Virginia (0.8 mi) · Sponsor: Stryker Instruments

See eligibility & contact on ClinicalTrials.gov (NCT03072927)

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought

Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT04852887)

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Phase 3 Interventional 356 participants sought

Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT06958328)

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma Phase 3 Interventional 1,295 participants sought

Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05812807)

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

Treatment Resistant Depression N/A Interventional 6,800 participants sought

Marshall University Joan C. Edwards School of Medicine — Huntington, West Virginia (0.8 mi) · Sponsor: LivaNova

See eligibility & contact on ClinicalTrials.gov (NCT03887715)

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

Prediabetic State, Atherosclerosis Phase 4 Interventional 7,410 participants sought

Huntington VA Medical Center, Huntington, WV — Huntington, West Virginia (0.8 mi) · Sponsor: VA Office of Research and Development

See eligibility & contact on ClinicalTrials.gov (NCT02915198)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought

Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT06172296)

Return to Play After ACL Reconstruction With Bone Marrow Aspirate, DBM, and an Internal Brace

Anterior Cruciate Ligament Rupture N/A Observational 450 participants sought

Marshall University — Huntington, West Virginia (0.8 mi) · Sponsor: Marshall University

See eligibility & contact on ClinicalTrials.gov (NCT06294314)

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Pancreatic Neoplasm N/A Observational 770 participants sought

Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

See eligibility & contact on ClinicalTrials.gov (NCT04239573)

Actively enrolling

Studies you may be able to join near Huntington

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Google-rated

Top-rated research centers in Huntington

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Health Research Systems

★ 3.5

7 Stonecrest Dr, Huntington, WV 25701

(304) 529-4453

Website

"Had a great experience getting a drug screening at Health Research Systems in Huntington, WV. The staff was courteous, efficient, and kept everything…"

— Gabriels Travel Secrets, 5★

Marshall University Joan C. Edwards School of Medicine

★ 4.8

1600 Medical Center Dr, Huntington, WV 25701

(304) 691-1700

Website

"Wonderful campus, friendly staff, and delightful students"

— Sunny “SUNNY” Sturgell- Morris, 5★

Marshall Health

★ 2.3

1600 Medical Center Dr, Huntington, WV 25701

(304) 691-1600

Website

CAMC Clinical Trials Center

★ 5.0

3100 MacCorkle Ave SE #806, Charleston, WV 25304

(304) 388-9944

Website

Clinical trials in Huntington: what's recruiting

The Huntington area currently has 55 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Huntington, the most active research areas are:

Cancer & Oncology14 studies
Liver & Kidney2 studies
Heart & Vascular1 studies
Lungs & Breathing1 studies
Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Huntington, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Huntington

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Huntington participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Huntington pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

Do I need to be sick to join a clinical trial in Huntington?

No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.

Are clinical trials in Huntington safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

How often do new paid studies open in Huntington?

Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Huntington.

Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Huntington typically complete one or two studies per year.

Paid clinical trials near Huntington

Other metros within reach

Columbus, OH1,355 Lexington, KY473 Cincinnati, OH1,131 Dayton, OH307 Canton, OH305 Roanoke, VA190 Akron, OH396 Asheville, NC124

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts